Michael J. Sernyak, MD
- 16Articles
- 27.4KReads
- 1997–2012Active
- 24Collaborators
- 36Citations
About
Michael J. Sernyak, MD, has published extensively on topics related to psychopharmacology, metabolic disorders, and patient care in psychiatric populations. His work focuses on the metabolic risks associated with antipsychotic medications, including weight gain, insulin resistance, and cardiovascular disease, particularly in patients with schizophrenia, schizoaffective disorder, bipolar disorder, and mood disorders. He has contributed to studies on monitoring and management strategies for second-generation antipsychotics and the clinical implications of antipsychotic coprescribing. His research has appeared in Psychiatrist.com between 1997 and 2012.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
